Skip to main content

Featured Studies

Office of Patient Recruitment

This web page makes it easy to search for featured research studies at the NIH Clinical Center. You can search for specific studies by entering keywords related to your symptoms in the search box or by using the sort and filter options.


To view a full list of all studies conducted at the NIH Clinical Center, visit Search the Studies.

Filter By

Visit Type

Patient or Healthy Volunteer

Age Group

Institution

Web Page Language

Reset All Filters
16 results
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction

Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction

Researchers at the National Institutes of Health seek healthy volunteers to participate in a research study. The purpose of this study is to test newly developed functional Magnetic Resonance Imaging (fMRI) scanning sequences that can be used in future protocols.
Learn More
If you have questions or would like to learn more about this study, contact 800-411-1222 and refer to study 15-AA-0186.
Drinking More Than 20 Drinks a Week?

Are You Drinking Too Much? Join NIH Research!

The National Institutes on Alcohol Abuse and Alcoholism (NIAAA) is recruiting heavy drinkers for a study to evaluate the safety of an investigational drug to treat signs and symptoms of alcohol associated liver damage. If you drink more than 20 alcoholic beverages per week, you may have this type of liver damage.
Learn More
If you have questions or would like to learn more about this study, contact 800-411-1222 and refer to study 000036-AA.
Phase II Interventional Study using Atorvastatin to Reduce Cisplatin-Induced Hearing Loss among Individuals with Head and Neck Cancer

Phase II Interventional Study using Atorvastatin to Reduce Cisplatin-Induced Hearing Loss among Individuals with Head and Neck Cancer

Doctors at the National Institute on Deafness and Other Communication Disorders (NIDCD) are investigating the effectiveness of atorvastatin (a drug used to lower “bad“ cholesterol and fats such as LDL, and triglycerides, and raise “good“ cholesterol such as HDL, in the blood) at reducing the incidence of hearing loss in patients treated with cisplatin for head and neck cancer.

Learn More
If you have questions or would like to learn more about this study, contact 800-411-1222 and refer to study 21-DC-0002.
Phase II Interventional Study using Atorvastatin to Reduce Cisplatin-Induced Hearing Loss among Individuals with Head and Neck Cancer

Phase II Interventional Study using Atorvastatin to Reduce Cisplatin-Induced Hearing Loss among Individuals with Head and Neck Cancer (En español)

Doctors at the National Institute on Deafness and Other Communication Disorders (NIDCD) are investigating the effectiveness of atorvastatin (a drug used to lower “bad“ cholesterol and fats such as LDL, and triglycerides, and raise “good“ cholesterol such as HDL, in the blood) at reducing the incidence of hearing loss in patients treated with cisplatin for head and neck cancer. (En español)

Learn More
If you have questions or would like to learn more about this study, contact 800-411-1222 and refer to study 21-DC-0002.
Was this page helpful?